FALINTOLOL OXALATE

Description
Sources: https://link.springer.com/chapter/10.1007/978-1-4757-2085-3_6 | https://www.ncbi.nlm.nih.gov/pubmed/6148422 | https://www.ncbi.nlm.nih.gov/pubmed/2903204

Fallntolol is a beta-adrenergic receptor antagonist. Falintolol does not produce any noteworthy side effects and is capable of being an effective beta-blocking agent in open-angle glaucoma therapy.

Originator

Approval Year

PubMed

Title	Date	PubMed

Name

Type

Language

FALINTOLOL OXALATE

Common Name

English

FALINTOLOL OXALATE, (±)-

Common Name

English

ETHANONE, 1-CYCLOPROPYL-, O-(3-((1,1-DIMETHYLETHYL)AMINO)-2-HYDROXYPROPYL)OXIME, ETHANEDIOATE (1:1) (SALT)

Systematic Name

English

Code System Code Type Description

FDA UNII

8ZG1XG255D

Created by admin on Sat Dec 16 19:28:46 GMT 2023 , Edited by admin on Sat Dec 16 19:28:46 GMT 2023

PRIMARY

CAS

99051-41-9

Created by admin on Sat Dec 16 19:28:46 GMT 2023 , Edited by admin on Sat Dec 16 19:28:46 GMT 2023

ALTERNATIVE

CAS

88134-93-4

Created by admin on Sat Dec 16 19:28:46 GMT 2023 , Edited by admin on Sat Dec 16 19:28:46 GMT 2023

PRIMARY

All of the following components must be present:


					62NN1Y9V7S

FALINTOLOL OXALATE, (Z)-


					94XX0MT81V

FALINTOLOL OXALATE, (E)-

ACTIVE MOIETY


					733BXR9780

FALINTOLOL

SUBSTANCE RECORD


					8ZG1XG255D

FALINTOLOL OXALATE

DescriptionSources: https://link.springer.com/chapter/10.1007/978-1-4757-2085-3_6 | https://www.ncbi.nlm.nih.gov/pubmed/6148422 | https://www.ncbi.nlm.nih.gov/pubmed/2903204

Originator

Approval Year

PubMed

All of the following components must be present:

Description
Sources: https://link.springer.com/chapter/10.1007/978-1-4757-2085-3_6 | https://www.ncbi.nlm.nih.gov/pubmed/6148422 | https://www.ncbi.nlm.nih.gov/pubmed/2903204